Healthy cell makes healthy people!

CEFObio, founded in 2011 with the long-term research experiences and know-hows on cells, is focusing on developing the new drugs as the fundamental cell therapy agents for thecell regeneration and the incurable diseases that have been doctorless until now.CEFObio is currently conducting the clinical trials with its most advanced pipeline for the osteogenic differentiation cell therapy agent that induces the patient's own bone regeneration and is aiming for the approval as the world's first stem cell therapy agent to have provedthe bone regeneration mechanism.For our next pipeline, we are developing the anti-cancer NK cell therapy agent that has almost no side effects and enables the complete cure as the cell therapy agent that utilizes the human immune system. Global biotrends are slowly moving towards the cell and gene therapies.CEFObio, which is more confident than anyone else in cell culture and differentiation technology, aims to become the company that contributes to the dream of human healthrealization.